Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
Ovarian Cancer - Medicare Access (Medicare patients only)
Status
ClosedThis fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Fund Type
CopayPremium (Medicare Part B only)
Maximum Award Level
Pharmacy Card Fund
YesMinimum CopayReimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium
Reimbursement Amount
Household Income Limit
400% of the Federal Poverty Level(adjusted for household size and high
cost of living areas)
Treatments Covered
- Abraxane
- Adriamycin
- Adrucil
- Alimta
- Alkeran
- Amifostine
- Anastrozole
- Arimidex
- Aromasin
- Avastin
- Bevacizumab
- Bevacizumab-awwb
- Bleo 15k
- Bleomycin
- Camptosar
- Capecitabine
- Carac
- Carboplatin
- Cisplatin
- Cosmegen
- Cyclophosphamide
- Docefrez
- Docetaxel
- Doxil
- Doxorubicin
- Doxorubicin Liposomal
- Efudex
- Elahere
- Eligard
- Ethyol
- Etopophos
- Etoposide
- Evomela
- Exemestane
- Femara
- Fluoroplex
- Fluorouracil
- Gemcitabine
- Gemzar
- Hexalen
- Hycamtin
- Ifex
- Ifosfamide
- Irinotecan
- Letrozole
- Leucovor Calcium
- Leucovorin
- Leuprolide
- Linodox 50
- Lupron Depot
- Lynparza
- Megace
- Megace Es
- Megestrol
- Megestrol Acetate
- Melphalan
- Mesna
- Mesnex
- Mvasi
- Navelbine
- Oxaliplatin
- Paclitaxel
- Paraplatin
- Rubraca
- Soltamox
- Tamoxifen
- Taxol
- Taxotere
- Tepadina
- Thiotepa
- Tolak
- Toposar
- Topotecan
- Velban
- Vinblastine
- Vincasar Pfs
- Vincristine
- Vinorelbine
- Votrient
- Xeloda
- Zejula
- Zirabev
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of ovarian cancer.
Grant Utilization
HealthWell estimates that patients use an average of $2,045 during their 12-month grant period for this disease area.
Consider Premium Assistance
Under this fund, HealthWell can assist with premium costs. Medicare supplemental policies can help with cost shares related to many aspects of your health care. Using a HealthWell grant to cover premiums may be a better option than treatment-specific cost shares.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
-
This is a Medicare Access Fund. In order to qualify for assistance through this fund, you must have Medicare. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Ovarian Cancer
Ovarian cancer is a growth of abnormal malignant cells that begins in the ovaries. According to the Ovarian Cancer Research Fund Alliance (OCRFA) ovarian tumors can be benign (noncancerous) or malignant (cancerous). Malignant cancer cells in the ovaries can metastasize directly to other organs in the pelvis and abdomen or through the bloodstream or lymph nodes to other parts of the body. Ovarian cancer is the number one cause of gynecologic cancer deaths. Over 22,000 new cases are diagnosed each year and 50% of those diagnosed are age 63 or older. Source: Ovarian Cancer Research Fund Alliance (OCRFA)
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.
